WHO grants Emergency Use Listing to JnJ Single-Shot COVID-19 vaccine Ruchika Sharma13 March 2021 12:38 PM ISTThe Johnson & Johnson COVID-19 single-shot vaccine is compatible with standard vaccine storage and distribution channels enabling delivery to remote...
Lack of uniform test for carcinogenic substances in JnJ baby products: NCPCR issues summons to CDSCO, DGCI Ruchika Sharma9 March 2021 2:00 PM ISTThe NCPCR also asked both the DCGI and the CDSCO as to why the latter has not regulated the standards and ensured uniformity in the testing methods.
Australian court upholds landmark suit against Johnson n Johnson for negligent marketing of pelvic mesh implants Ruchika Sharma6 March 2021 3:01 PM ISTNew Delhi: An Australian court upheld a landmark class-action lawsuit against Johnson & Johnson for "negligent" marketing of pelvic mesh implants...
J&J gets US CDC Advisory Committee Recommendation for single-shot COVID-19 vaccine Ruchika Sharma1 March 2021 12:46 PM ISTNew Brunswick: Johnson & Johnson has recently announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on...
Johnson and Johnson applies to WHO for Emergency Use Listing of Covid-19 vaccine Ruchika Sharma23 Feb 2021 9:00 AM ISTNew Brunswick: Johnson & Johnson has recently announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL)...
Brandname Misuse: Spurious Johnson and Johnson sutures racket busted, 5 arrested Ruchika Sharma20 Jan 2021 1:21 PM ISTAs per the complaint on behalf of Johnson and Johnson, Pawar said that during a routine survey of chemist shops in the vicinity of the Sir J.J. Marg...
Johnson and Johnson to submit single-dose COVID-19 vaccine trial data: Bloomberg Ruchika Sharma13 Jan 2021 1:30 PM ISTNew Delhi: Johnson & Johnson's preliminary data from the South African arm of a phase 3 Covid-19 vaccine trial will be ready for submission to...
JnJ enrolls about 45,000 participants for COVID vaccine late-stage trial Ruchika Sharma20 Dec 2020 9:15 AM ISTJ&J said it plans to submit an emergency use authorization application to the USFDA in February if the data from the study is safe and effective.
